Current/ Expected Orderbook/ Pending Orders?

The company has a good order bank building up as of Q3 FY24. Orders are coming in steadily, expected to be executed in the next few months. Demand slowdown is viewed as short-term, with recovery expected from FY25 onwards. Multiple real estate projects nearing completion will drive higher consumption of sanitaryware and faucetware items next year. Institutional sales from government, educational, hospitality, and medical projects are also expected to contribute positively to the order pipeline. Overall, the orderbook outlook is strong with confidence in future growth post the temporary demand

Any current/future new fundraising through debt or equity?

No mention of any current or planned fundraising through debt or equity in the transcript. Expansion programs, including the sanitaryware greenfield project and faucetware capacity increase, are being funded entirely through internal accruals. Management has emphasized maintaining strong financial discipline with healthy cash reserves (Rs. 768 crore as of Dec 31, 2023). The company is focused on returning excess cash to shareholders via increased dividends and potentially exploring buybacks. No inorganic acquisition plans or new capital raise initiatives are currently under consideration; expa

Any current/future capex/capital investment/strategic investment?

Faucetware expansion: Brownfield expansion from 3 lakh to 4 lakh units is in ramp-up phase with 60% completion; capacity civil work prepared for future increase from 4 lakh to 6 lakh units. No major capex planned for next 3-5 years for faucetware expansion. Sanitaryware greenfield project: Substantial land acquisition (75% done as of Jan 2024), expected completion by June 2024 for remaining; estimated project cost Rs. 125-130 crore including land. Plant expected operational within 18 months from start. Expansion and operationalization to be funded through internal accruals; no major inorga

Future growth expectations in sales/revenue/volumes?

The demand slowdown experienced in Q3 FY24 is viewed as temporary, with improvement expected starting FY25 onwards. Real estate projects nearing completion are anticipated to drive increased consumption of sanitaryware, faucetware, tiles, and wellness products from FY25. Institutional sales from government and hospitality sectors are also expected to contribute positively. The company sees growth resuming in Q4 FY24, with March being the strongest month for sales. FY25 growth outlook remains encouraging, supported by macroeconomic factors including a projected 7% GDP growth. Expansion in fauce

Future growth expectations in earnings/operating earnings/profits/EPS?

The company sees the current demand slowdown as a short-term phenomenon expected to improve from FY25 onward, supported by real estate project completions and increasing consumption of sanitaryware and faucetware. March is typically the best month of the year for sales, and improvement was already seen starting February. Management remains committed to sustainable growth and improving financial performance over the medium to long term. Prior revenue targets (around Rs. 2,500 crore by March '25 and Rs. 2,900 crore by September '25) are still intact, with guidance to be updated in the next

Cera Sanitaryware LtdQ4 FY24

Cera Sanitaryware Ltd Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹5,926P/E: 38.8Market Cap: ₹8.1K Cr

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Order

Yes

Capex

Yes

2 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→The demand slowdown experienced in Q3 FY24 is viewed as temporary, with improvement expected starting FY25 onwards.
→Real estate projects nearing completion are anticipated to drive increased consumption of sanitaryware, faucetware, tiles, and wellness products from FY25.
→Institutional sales from government and hospitality sectors are also expected to contribute positively.
→The company sees growth resuming in Q4 FY24, with March being the strongest month for sales.
→FY25 growth outlook remains encouraging, supported by macroeconomic factors including a projected 7% GDP growth.
→Expansion in faucetware capacity (from 4 lakh to 6 lakh pieces) and sanitaryware greenfield capacity will enable meeting future demand.
→Management expects stable product mix proportions with a slight increase in faucetware contribution.
→Continuous innovation and premium product introductions, which contribute significantly to revenues, are expected to fuel growth.
→Cash utilization focused on internal accrual-funded expansions, ongoing dividend payouts, and potential buybacks underline financial strength supporting growth.

Margin guidance

Category 3

→The company sees the current demand slowdown as a short-term phenomenon expected to improve from FY25 onward, supported by real estate project completions and increasing consumption of sanitaryware and faucetware.
→March is typically the best month of the year for sales, and improvement was already seen starting February.
→Management remains committed to sustainable growth and improving financial performance over the medium to long term.
→Prior revenue targets (around Rs. 2,500 crore by March '25 and Rs. 2,900 crore by September '25) are still intact, with guidance to be updated in the next earnings call.
→EBITDA margin dipped in Q3 due to increased advertising and sales promotion expenses but is expected to stabilize as demand recovers.
→Innovation and premiumization remain key growth levers, with new products introduced in the last three years contributing about 32-35% to turnover.
→Overall positive outlook with expected growth acceleration from FY25 onwards given better market conditions.

3 more insights locked — sign up free to unlock

Fundraise plans

→No mention of any current or planned fundraising through debt or equity in the transcript.
→Expansion programs, including the sanitaryware greenfield project and faucetware capacity increase, are being funded entirely through internal accruals.
→Management has emphasized maintaining strong financial discipline with healthy cash reserves (Rs. 768 crore as of Dec 31, 2023).
→The company is focused on returning excess cash to shareholders via increased dividends and potentially exploring buybacks.
→No inorganic acquisition plans or new capital raise initiatives are currently under consideration; expansions are prioritized for completion first.
→Any updates on fundraising or changes in plans would likely be communicated in future earnings calls.

Order book

Yes

→The company has a good order bank building up as of Q3 FY24.
→Orders are coming in steadily, expected to be executed in the next few months.
→Demand slowdown is viewed as short-term, with recovery expected from FY25 onwards.
→Multiple real estate projects nearing completion will drive higher consumption of sanitaryware and faucetware items next year.
→Institutional sales from government, educational, hospitality, and medical projects are also expected to contribute positively to the order pipeline.
→Overall, the orderbook outlook is strong with confidence in future growth post the temporary demand slowdown.

Capex plans

Yes

→Faucetware expansion: Brownfield expansion from 3 lakh to 4 lakh units is in ramp-up phase with 60% completion; capacity civil work prepared for future increase from 4 lakh to 6 lakh units. No major capex planned for next 3-5 years for faucetware expansion.
→Sanitaryware greenfield project: Substantial land acquisition (75% done as of Jan 2024), expected completion by June 2024 for remaining; estimated project cost Rs. 125-130 crore including land. Plant expected operational within 18 months from start.
→Expansion and operationalization to be funded through internal accruals; no major inorganic acquisitions or new capex planned currently.
→Management exploring options like increased dividend payout and possible share buybacks to utilize excess cash.
→Current focus is on completing ongoing expansions before considering further capital investments or acquisitions.

How does Cera Sanitaryware Ltd rank vs peers in ?

Pro feature

1Cera Sanitaryware Ltd

Rev 3Mar 3

See full sector rankings

Want more stocks like Cera Sanitaryware Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio